ReviewJournal of clinical medicine2026
Relationship Between Vitamin D Serum Levels and the Severity of Atopic Dermatitis-A Mapping Review of Evidence with Emphasis on Geography.
Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Serum 25-hydroxyvitamin D levels in pediatric atopic dermatitis: seasonal variability and association with disease severity.European journal of pediatrics · 2026Article
- The Role of Fat-Soluble Vitamins in the Prevention and Management of Atopic Dermatitis.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease with early-age onset. While vitamin D (VitD) has been associated with AD alleviation, geographical factors should be considered as VitD synthesis depends on sunlight exposure and dietary intake. We conducted a mapping review to identify geography-related evidence gaps in interventional and observational studies on the VitD-AD inverse association. We analyzed latitude and the Human Development Index (HDI) as background geographical factors. The review identified 38 studies (17 interventional, 21 observational), of which 26 confirmed the inverse VitD-AD association. Of all reviewed studies, 73% were from latitudes above 35° N, and 70.3% were from developed countries. The median latitude and HDI were 37.5° N and 0.915, respectively. Conversely, only 5.4% of studies were from Africa and 8.1% from Latin America. Studies that did not confirm the inverse VitD-AD association tended to be concentrated in developed countries at higher latitudes (median latitude 42.4° N, median HDI 0.937). Only 8.1% of all studies were from low-latitude developed countries, and among interventional studies this share was even lower (6.3%). In addition, 52.6% of studies lacked data on baseline VitD variability and 13.2% had no baseline VitD data at all. More thorough data reporting and additional clinical studies from countries that do not follow the high latitude/high HDI overlap pattern would facilitate future meta-analyses aimed at clarifying the role of VitD in AD treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.